At Advanced Innovative Partners, we are at the forefront of pharmaceutical development, creating groundbreaking drugs across a diverse range of therapeutic areas, modalities, and technologies.
TRT Technology
Targeted Radiation Therapy (TRT)
Targeted radiation therapy is revolutionizing cancer treatment by enhancing the delivery of tumoricidal doses to malignancies while minimizing damage to healthy tissue. Recent advances in molecular imaging and radiopharmaceutical development have enabled radiation to be precisely directed at tumor cells based on unique molecular signatures. This approach is fueling expansion of the global radiotherapy market, forecast to grow at a CAGR of 6% to reach $8.6 billion by 2023.
1. Precision Radiation
A targeting agent, such as a small molecule or antibody, is coupled
with a radioisotope “payload.” This targeting agent exhibits a specific
affinity to distinctive biomarkers present on the exterior of cancerous
or diseased cells. The choice of radioisotope determines whether the
approach involves imaging or therapeutic intervention.
2. Intravenous Administration
The precision radiation medication is introduced intravenously,
allowing it to be carefully delivered into the bloodstream, from where
it disperses systematically throughout the entire body, reaching its
intended targets.
3. Precision Delivery Approach
Targeted radiation treatment actively seeks out cancerous or diseased
cells, even in the case of small metastases where the disease has
spread, and exhibits a specific affinity for its intended target. This
approach stands in contrast to conventional radiation therapy, which
typically confines treatment to a localized tumor site.
4. Diagnosis and treatment
Certain radioisotopes possess physical characteristics that can be
harnessed for diagnostic and staging purposes in the imaging of
cancer or rare diseases. Meanwhile, radioisotopes emitting higher
doses of alpha and beta radiation hold the potential for therapeutic
applications in eradicating cancerous or diseased cells.